Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Pfizer will copromote Searle's COX-2 inhibitors in U.S.

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

Small-molecule chemokine receptor antagonists from Teijin

Feb. 18, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

New NSAID from Maruho and Toyama (M-5011) compares favorably with known compounds

Feb. 16, 1998

Pharmacokinetic/pharmacodynamic characterization of CP-105696 in volunteers

Feb. 13, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Feb. 12, 1998

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.